225 related articles for article (PubMed ID: 18559093)
1. Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha.
Scotto L; Narayan G; Nandula SV; Subramaniyam S; Kaufmann AM; Wright JD; Pothuri B; Mansukhani M; Schneider A; Arias-Pulido H; Murty VV
Mol Cancer; 2008 Jun; 7():58. PubMed ID: 18559093
[TBL] [Abstract][Full Text] [Related]
2. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression.
Scotto L; Narayan G; Nandula SV; Arias-Pulido H; Subramaniyam S; Schneider A; Kaufmann AM; Wright JD; Pothuri B; Mansukhani M; Murty VV
Genes Chromosomes Cancer; 2008 Sep; 47(9):755-65. PubMed ID: 18506748
[TBL] [Abstract][Full Text] [Related]
3. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
4. Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions.
Linxweiler M; Bochen F; Schick B; Wemmert S; Al Kadah B; Greiner M; Hasenfus A; Bohle RM; Juhasz-Böss I; Solomayer EF; Takacs ZF
BMC Cancer; 2016 Aug; 16(1):676. PubMed ID: 27553742
[TBL] [Abstract][Full Text] [Related]
5. Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels.
Muralidhar B; Goldstein LD; Ng G; Winder DM; Palmer RD; Gooding EL; Barbosa-Morais NL; Mukherjee G; Thorne NP; Roberts I; Pett MR; Coleman N
J Pathol; 2007 Aug; 212(4):368-77. PubMed ID: 17471471
[TBL] [Abstract][Full Text] [Related]
6. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
Hopman AH; Theelen W; Hommelberg PP; Kamps MA; Herrington CS; Morrison LE; Speel EJ; Smedts F; Ramaekers FC
J Pathol; 2006 Dec; 210(4):412-9. PubMed ID: 17054308
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
8. MiR-21-5p, miR-34a, and human telomerase RNA component as surrogate markers for cervical cancer progression.
Zhu Y; Han Y; Tian T; Su P; Jin G; Chen J; Cao Y
Pathol Res Pract; 2018 Mar; 214(3):374-379. PubMed ID: 29487007
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations at 5p15: a potential marker for progression of precancerous lesions of the uterine cervix.
Mitra AB; Murty VV; Singh V; Li RG; Pratap M; Sodhani P; Luthra UK; Chaganti RS
J Natl Cancer Inst; 1995 May; 87(10):742-5. PubMed ID: 7563151
[TBL] [Abstract][Full Text] [Related]
10. Mapping common deleted regions on 5p15 in cervical carcinoma and their occurrence in precancerous lesions.
Arias-Pulido H; Narayan G; Vargas H; Mansukhani M; Murty VV
Mol Cancer; 2002 Oct; 1():3. PubMed ID: 12392596
[TBL] [Abstract][Full Text] [Related]
11. Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles.
Muralidhar B; Winder D; Murray M; Palmer R; Barbosa-Morais N; Saini H; Roberts I; Pett M; Coleman N
J Pathol; 2011 Aug; 224(4):496-507. PubMed ID: 21590768
[TBL] [Abstract][Full Text] [Related]
12. Mapping the sites of putative tumor suppressor genes at 6p25 and 6p21.3 in cervical carcinoma: occurrence of allelic deletions in precancerous lesions.
Chatterjee A; Pulido HA; Koul S; Beleño N; Perilla A; Posso H; Manusukhani M; Murty VV
Cancer Res; 2001 Mar; 61(5):2119-23. PubMed ID: 11280775
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results.
Luhn P; Houldsworth J; Cahill L; Schiffman M; Castle PE; Zuna RE; Dunn ST; Gold MA; Walker J; Wentzensen N
Gynecol Oncol; 2013 Sep; 130(3):595-600. PubMed ID: 23769811
[TBL] [Abstract][Full Text] [Related]
14. Distinct telomere length regulation in premalignant cervical and endometrial lesions: implications for the roles of telomeres in uterine carcinogenesis.
Maida Y; Kyo S; Forsyth NR; Takakura M; Sakaguchi J; Mizumoto Y; Hashimoto M; Nakamura M; Nakao S; Inoue M
J Pathol; 2006 Oct; 210(2):214-23. PubMed ID: 16909412
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase I deficiency results in chromosomal alterations in cervical cancer cells.
Kjeldsen E; Tordrup D; Hübner GM; Knudsen BR; Andersen FF
Anticancer Res; 2010 Sep; 30(9):3257-65. PubMed ID: 20944095
[TBL] [Abstract][Full Text] [Related]
16. Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution.
Chu TY; Shen CY; Lee HS; Liu HS
Genes Chromosomes Cancer; 1999 Feb; 24(2):127-34. PubMed ID: 9885979
[TBL] [Abstract][Full Text] [Related]
17. Gain and overexpression of the oncostatin M receptor occur frequently in cervical squamous cell carcinoma and are associated with adverse clinical outcome.
Ng G; Winder D; Muralidhar B; Gooding E; Roberts I; Pett M; Mukherjee G; Huang J; Coleman N
J Pathol; 2007 Jul; 212(3):325-34. PubMed ID: 17516585
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques.
Ziegert C; Wentzensen N; Vinokurova S; Kisseljov F; Einenkel J; Hoeckel M; von Knebel Doeberitz M
Oncogene; 2003 Jun; 22(25):3977-84. PubMed ID: 12813471
[TBL] [Abstract][Full Text] [Related]
19. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
[TBL] [Abstract][Full Text] [Related]
20. Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence.
Conesa-Zamora P; Torres-Moreno D; Isaac MA; Pérez-Guillermo M
Exp Mol Pathol; 2013 Oct; 95(2):151-5. PubMed ID: 23827764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
